Melanoma

Showing NaN - NaN of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Trial in Aurora (PI-88)

Completed
  • Melanoma
  • Aurora, Colorado
    University of Colorado Health Sciences Center
Jun 21, 2022

Melanoma Trial in Worldwide (Nivolumab 3 mg/kg IV, Ipilimumab 1 mg/kg IV, Nivolumab 1 mg/kg IV)

Completed
  • Melanoma
  • Nivolumab 3 mg/kg IV
  • +4 more
  • Aurora, Colorado
  • +56 more
Jun 17, 2022

Unresectable And Metastatic Melanoma: The Optimize Study

Completed
  • Melanoma
    • Muscle Shoals, Alabama
    • +65 more
    May 17, 2022

    Cancer, Melanoma Trial in Worldwide (drug, biological, other)

    Recruiting
    • Cancer
    • Melanoma
    • Springdale, Arkansas
    • +70 more
    May 16, 2022

    Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

    Recruiting
    • Advanced Solid Tumor
    • +9 more
    • Phoenix, Arizona
    • +20 more
    May 2, 2022

    Melanoma Trial in France, Germany, United States (Talimogene laherparepvec, Ipilimumab)

    Completed
    • Melanoma
    • Tucson, Arizona
    • +39 more
    Mar 9, 2022

    Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States

    Recruiting
    • Pancreatic Cancer
    • +49 more
      • Colorado Springs, Colorado
      • +80 more
      Feb 22, 2022

      Melanoma Trial in Aurora (Knowledge Assessment)

      Completed
      • Melanoma
      • Knowledge Assessment
      • Aurora, Colorado
        University of Colorado
      Jan 3, 2022

      Melanoma Trial in Canada, United States (POL-103A, POL-103A without API)

      Terminated
      • Melanoma
      • POL-103A
      • POL-103A without API
      • Chandler, Arizona
      • +64 more
      Dec 6, 2021

      Melanoma Trial in United States (Ipilimumab, Nivolumab)

      Completed
      • Melanoma
      • Duarte, California
      • +35 more
      Sep 8, 2021

      Melanoma Trial in Worldwide (nivolumab, ipilimumab)

      Completed
      • Melanoma
      • nivolumab
      • ipilimumab
      • Tucson, Arizona
      • +123 more
      Aug 24, 2021

      Clear Cell Renal Cell Carcinoma (ccRCC), Melanoma, NSCLC (NSCLC) Trial in United States (CB-839, Nivolumab)

      Completed
      • Clear Cell Renal Cell Carcinoma (ccRCC)
      • +2 more
      • Scottsdale, Arizona
      • +16 more
      Aug 16, 2021

      Melanoma, Skin Cancer Trial in Worldwide (BMS-986205, Nivolumab, Placebo)

      Completed
      • Melanoma
      • Skin Cancer
      • Los Angeles, California
      • +62 more
      Jun 18, 2021

      Melanoma, Unresectable (Stage III) Melanoma, Metastatic (Stage IV) Melanoma Trial in United States (Omaveloxolone Capsules (2.5

      Completed
      • Melanoma
      • +2 more
      • Omaveloxolone Capsules (2.5 mg/capsule)
      • +4 more
      • Mobile, Alabama
      • +9 more
      Jun 4, 2021

      Melanoma Trial in United States (TAK-580, TAK-202, vedolizumab)

      Terminated
      • Melanoma
      • Tucson, Arizona
      • +13 more
      Mar 3, 2021

      Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Australia, United States (AMG 232, Trametinib, Dabrafenib)

      Completed
      • Advanced Malignancy
      • +6 more
      • AMG 232
      • +2 more
      • Los Angeles, California
      • +6 more
      Mar 24, 2021

      Melanoma Trial in Worldwide (Nivolumab, Ipilimumab)

      Withdrawn
      • Melanoma
      • Nivolumab
      • Ipilimumab
      • Gilbert, Arizona
      • +117 more
      Mar 17, 2021

      Melanoma Trial in Worldwide (GSK 2132231A, Placebo)

      Terminated
      • Melanoma
      • GSK 2132231A
      • Placebo
      • Birmingham, Alabama
      • +256 more
      Feb 5, 2021

      Melanoma Trial in Worldwide (Dabrafenib, Vemurafenib, Trametinib)

      Completed
      • Melanoma
      • Birmingham, Alabama
      • +204 more
      Feb 8, 2021

      Breast Cancer, NSCLC, Melanoma Trial in Worldwide (Abemaciclib)

      Completed
      • Breast Cancer
      • +3 more
      • Duarte, California
      • +43 more
      Dec 17, 2020

      B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

      Completed
      • B-cell Malignancies
      • +7 more
      • Nivolumab (Phase 1)
      • +4 more
      • Birmingham, Alabama
      • +23 more
      Aug 26, 2020

      Melanoma Trial in Worldwide (pembrolizumab + epacadostat, pembrolizumab + )

      Completed
      • Melanoma
      • pembrolizumab + epacadostat
      • pembrolizumab + placebo
      • Birmingham, Alabama
      • +128 more
      Aug 14, 2020

      Melanoma Trial in Worldwide (Vemurafenib, Placebo)

      Completed
      • Melanoma
      • Birmingham, Alabama
      • +206 more
      Jul 11, 2019

      Mucosal Lentiginous Melanoma, Acral Melanoma, Melanoma Trial in United States (Nilotinib)

      Completed
      • Mucosal Lentiginous Melanoma
      • +2 more
      • Santa Monica, California
      • +7 more
      Oct 16, 2018

      Renal Cell Carcinoma, Melanoma, Lung Cancer Trial in United States (Infliximab + Prednisone, Methylprednisolone + Prednisone)

      Withdrawn
      • Renal Cell Carcinoma
      • +2 more
      • Infliximab + Prednisone
      • Methylprednisolone + Prednisone
      • Los Angeles, California
      • +9 more
      Oct 5, 2018